Great topic!
One could think that at the stage that we are at in terms of HIV knowledge and compared to say 15-20 years, adherence to therapy would not be a problem, even more in the US. However, I can see how this can be a challenging task. Regarding your population, how are these individuals that need PrEP are identified? Are there any factors in common, other than ethnicity, among those who tend not to be adherent to therapy that you can detect as a target?
I am not familiar with this topic, what navigation and panel management-based interventions entail?